XML 12 R2.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 6,013,318 $ 13,353,543
Investment securities - available for sale, at fair value 15,702,388 14,257,998
Accrued interest receivable on investment securities 65,673 68,309
Advances and deposits on clinical programs and other current assets 1,271,670 451,293
Total current assets 23,053,049 28,131,143
Property and equipment (at cost, less accumulated depreciation of $2,627,919 and $2,968,259, respectively) 386,671 184,627
Other assets:    
In-process research and development, net 15,736,491 15,736,491
Goodwill 1,976,101 1,976,101
Operating lease right-of-use assets, net 1,609,882
Other intangible assets, net 454,634 568,292
Deposits and other assets 370,210 258,933
Total other assets 20,147,318 18,539,817
Total assets 43,587,038 46,855,587
Current liabilities:    
Accounts payable - trade 3,392,593 3,020,638
Other accrued liabilities 2,389,482 2,585,898
Operating lease liability - current portion 366,541
Deferred revenue - current portion 500,000 500,000
Total current liabilities 6,648,616 6,106,536
Earn-out milestone liability 5,904,725 8,907,664
Note Payable, net of deferred financing costs 9,608,761 9,417,037
Operating lease liability - non-current portion 1,343,225
Deferred revenue - non-current portion 1,250,000 1,500,000
Other liabilities - non-current 63,278
Total liabilities 24,755,327 25,994,515
Commitments and contingencies
Stockholders' equity:    
Preferred Stock - $0.01 par value (100,000 shares authorized, and no shares issued or outstanding at June 30, 2019 and December 31, 2018)
Common stock - $0.01 par value (112,500,000 shares authorized; 21,002,629 and 18,832,168 shares issued at June 30, 2019 and December 31, 2018, respectively, and 21,002,295 and 18,831,834 shares outstanding at June 30, 2019 and December 31, 2018, respectively) 210,026 188,322
Additional paid-in capital 300,549,511 294,393,313
Accumulated other comprehensive gain 94,576 29,872
Accumulated deficit (281,937,214) (273,665,247)
Total stockholders' equity before treasury stock 18,916,899 20,946,260
Treasury stock, at cost (334 shares at June 30, 2019 and December 31, 2018) (85,188) (85,188)
Total stockholders' equity 18,831,711 20,861,072
Total liabilities and stockholders' equity $ 43,587,038 $ 46,855,587